Us Bancorp \De\ Biogen Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Biogen Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 20,214 shares of BIIB stock, worth $3.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

20,214

Previous 23,969 15.67%

Holding current value

$3.51 Million

Previous $5.56 Million 29.48%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$189.07 - $236.8 $709,957 - $889,184	-3,755 Reduced 15.67%	20,214 $3.92 Million
Q2 2024 Aug 06, 2024	BUY	$190.52 - $236.72 $1.22 Million - $1.51 Million	6,393 Added 36.37%	23,969 $5.56 Million
Q1 2024 May 07, 2024	SELL	$212.02 - $267.71 $561,428 - $708,896	-2,648 Reduced 13.09%	17,576 $3.79 Million
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $151,361 - $182,199	-680 Reduced 3.25%	20,224 $5.23 Million
Q3 2023 Nov 03, 2023	SELL	$253.3 - $285.89 $628,184 - $709,007	-2,480 Reduced 10.61%	20,904 $5.37 Million
Q2 2023 Aug 09, 2023	SELL	$275.25 - $318.06 $245,798 - $284,027	-893 Reduced 3.68%	23,384 $6.66 Million
Q1 2023 May 09, 2023	SELL	$256.56 - $292.34 $449,749 - $512,472	-1,753 Reduced 6.73%	24,277 $6.75 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $439,750 - $534,306	1,742 Added 7.17%	26,030 $7.21 Million
Q3 2022 Oct 27, 2022	SELL	$194.69 - $268.46 $427,733 - $589,806	-2,197 Reduced 8.3%	24,288 $6.48 Million
Q2 2022 Aug 01, 2022	SELL	$187.54 - $223.02 $702,524 - $835,432	-3,746 Reduced 12.39%	26,485 $5.4 Million
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $1.16 Million - $1.47 Million	-6,006 Reduced 16.57%	30,231 $6.37 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $2.15 Million - $2.76 Million	-9,593 Reduced 20.93%	36,237 $8.7 Million
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $632,199 - $824,457	-2,234 Reduced 4.65%	45,830 $13 Million
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $2.74 Million - $4.38 Million	-10,560 Reduced 18.01%	48,064 $16.6 Million
Q1 2021 Apr 28, 2021	SELL	$242.95 - $284.63 $391,635 - $458,823	-1,612 Reduced 2.68%	58,624 $16.4 Million
Q4 2020 Feb 04, 2021	SELL	$236.26 - $355.63 $1.49 Million - $2.25 Million	-6,325 Reduced 9.5%	60,236 $14.7 Million
Q3 2020 Nov 10, 2020	SELL	$264.77 - $305.71 $1.32 Million - $1.53 Million	-5,004 Reduced 6.99%	66,561 $18.9 Million
Q2 2020 Aug 07, 2020	SELL	$258.66 - $342.55 $927,813 - $1.23 Million	-3,587 Reduced 4.77%	71,565 $19.1 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $3.83 Million - $4.85 Million	-14,230 Reduced 15.92%	75,152 $23.8 Million
Q4 2019 Feb 04, 2020	SELL	$220.06 - $304.07 $5.89 Million - $8.14 Million	-26,786 Reduced 23.06%	89,382 $26.5 Million
Q3 2019 Nov 08, 2019	SELL	$217.44 - $243.88 $2.33 Million - $2.61 Million	-10,700 Reduced 8.43%	116,168 $27 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $7.66 Million - $8.44 Million	-34,914 Reduced 21.58%	126,868 $29.7 Million
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $195,689 - $306,080	-903 Reduced 0.56%	161,782 $38.2 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $1.83 Million - $2.32 Million	6,571 Added 4.21%	162,685 $49 Million
Q3 2018 Nov 01, 2018	SELL	$293.51 - $383.83 $3.13 Million - $4.09 Million	-10,651 Reduced 6.39%	156,114 $55.2 Million
Q2 2018 Aug 08, 2018	BUY	$257.52 - $306.91 $377,009 - $449,316	1,464 Added 0.89%	166,765 $48.4 Million
Q1 2018 May 08, 2018	BUY	$260.13 - $367.91 $2.62 Million - $3.7 Million	10,057 Added 6.48%	165,301 $45.3 Million
Q4 2017 Feb 02, 2018	BUY	$307.64 - $344.58 $1.45 Million - $1.62 Million	4,706 Added 3.13%	155,244 $49.5 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $42.3 Million - $49.6 Million	150,538	150,538 $47.1 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account